Cantaloupe, Inc.
Cantaloupe, Inc. (CTLPP) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Cantaloupe, Inc. (CTLPP), featuring income statements, balance sheets, and cash flow data.
Cantaloupe, Inc. (CTLPP) Income Statement & Financial Overview
View the income breakdown for Cantaloupe, Inc. CTLPP across both annual and quarterly reports.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $73.72M | $70.84M | $72.66M | $67.90M |
| Cost of Revenue | $43.002M | $41.98M | $45.56M | $43.48M |
| Gross Profit | $30.72M | $28.85M | $27.10M | $24.41M |
| Gross Profit Ratio | $0.42 | $0.41 | $0.37 | $0.36 |
| R&D Expenses | $4.52M | $4.50M | $4.42M | $4.92M |
| SG&A Expenses | $16.62M | $17.38M | $17.96M | $14.30M |
| Operating Expenses | $24.56M | $24.74M | $24.97M | $19.21M |
| Total Costs & Expenses | $67.56M | $66.73M | $70.52M | $62.70M |
| Interest Income | $398000.00 | $447000.00 | $464000.00 | $657000.00 |
| Interest Expense | $993000.00 | $991000.00 | $987000.00 | $162000.00 |
| Depreciation & Amortization | $3.83M | $3.19M | $3.09M | $2.91M |
| EBITDA | $10.19M | $7.93M | $7.02M | $7.65M |
| EBITDA Ratio | $0.14 | $0.11 | $0.10 | $0.11 |
| Operating Income | $6.16M | $4.11M | $3.54M | $5.20M |
| Operating Income Ratio | $0.08 | $0.06 | $0.05 | $0.08 |
| Other Income/Expenses (Net) | -$794000.00 | -$358000.00 | -$591000.00 | -$459000.00 |
| Income Before Tax | $5.37M | $3.75M | $2.94M | $4.74M |
| Income Before Tax Ratio | $0.07 | $0.05 | $0.04 | $0.07 |
| Income Tax Expense | $395000.00 | $177000.00 | $739000.00 | $84000.00 |
| Net Income | $4.97M | $3.57M | $2.21M | $4.66M |
| Net Income Ratio | $0.07 | $0.05 | $0.03 | $0.07 |
| EPS | $0.07 | $0.04 | $0.03 | $0.06 |
| Diluted EPS | $0.07 | $0.04 | $0.03 | $0.06 |
| Weighted Avg Shares Outstanding | $73.11M | $73.07M | $72.82M | $72.85M |
| Weighted Avg Shares Outstanding (Diluted) | $74.73M | $73.92M | $74.17M | $74.07M |
The company's financials show resilient growth, with revenue advancing from $67.90M in Q3 2024 to $73.72M in Q2 2025. Gross profit remained healthy with margins at 42% in Q2 2025 compared to 36% in Q3 2024. Operating income hit $6.16M last quarter, sustaining a consistent 8% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $10.19M. Net income rose to $4.97M, while earnings per share reached $0.07. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan